🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of EIT-guided PEEP in ARDS Patients

RecruitingNAAges 19 Years - 90 YearsAllSoutheast University, China
NCT06990477 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Acute respiratory syndrome distress (ARDS) is a clinical common syndrome with high mortality. Mechanical ventilation (MV) is the cornerstone of management of ARDS but can lead to ventilator-induced lung injury. Positive end-expiratory pressure (PEEP), as one of main component of MV, has been widely used in the clinical practice. However, the PEEP selection is still a difficult problem for moderate to severe ARDS patients. EIT, an imaging tool evaluating the regional ventilation distribution at the bedside, can achieve the individual PEEP selection for all mechanically ventilated patients. Our previous study found that moderate to severe ARDS patients with higher recruitability could benefit from EIT-guided PEEP. This article compared the effect of PEEP titrated guided by EIT with fraction of inspired oxygen (FiO2)-PEEP table on the clinical outcomes in ARDS patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Age≥18 years 2. Moderate-to-severe ARDS, defined by the ARDS Definition Task Force in the Berlin definition (partial pressure of arterial oxygen \[PaO2\]:FiO2 ratio ≤200 mmHg with a PEEP ≥5 cmH2O) 3. Diagnosis of ARDS less than 72 hours Exclusion Criteria: 1. Expected to be mechanically ventilated for less than 48 hours 2. Severe chronic respiratory diseases requiring long-term home oxygen therapy or noninvasive MV 3. Undrained pneumothorax or subcutaneous emphysema 4. Contraindication to the use of EIT (pacemaker, automatic implantable cardioverter defibrillator, and implantable pumps) 5. Severe neuromuscular disease 6. Hemodynamic instability 7. Contraindications to hypercapnia, such as intracranial hypertension or acute coronary syndrome 8. Severe other organs dysfunction with a low expected survival (7 days) or palliative care 9. Severe liver disease (Child-Pugh Score ≥10) 10. Pregnancy 11. Refusal to sign the informed consent
💊

What it tests

  • EIT-guided PEEP
📍

Where

17 sites
Second Hospital of Anhui Medical University
Hefei, China
Department of Critical Care Medicine, Zhongshan Hospital of Fudan University
Shanghai, China
Department of Critical Care Medicine, Renji Hospital
Shanghai, China
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, China
Zhengzhou Central Hospital Affiliated to Zhengzhou University
Zhengzhou, China
The Affiliated Hospital of Hangzhou Normal University
Hangzhou, China
Zhongda Hospital, School of Medicine, Southeast University
Nanjing, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, China

…and 9 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy